05 Jun 2020 --- Supplement company Pendulum Therapeutics has launched a medical probiotic called Pendulum Glucose Control that can help manage Type 2 diabetes. The company affirms that the product’s specific bacterial strains can help metabolize fiber into butyrate, a short-chain fatty acid that is key to modulating insulin. The microbiome-targeted solution provides a novel avenue in diabetes management, as gut health and immunity have increasingly become spotlighted throughout industry.
